0%
Daily Market Update
26-May-20251 min readvipin kumar

Trump extends deadline for 50% tariffs on EU goods to July 9- Daily Market Update 26th May 2025

Get a Smart Summary Instantly

Prompt copied

President Donald Trump said he would extend the deadline for the European Union to face 50% tariffs until July 9 after a phone call with Commission President Ursula von der Leyen. Von der Leyen, who heads the EU’s executive arm, said earlier Sunday in a post on X that “Europe is ready to advance talks swiftly and decisively,” but “a good deal” will need “time until July 9.” That’s the date that Trump’s 90-day pause of his so-called reciprocal tariffs had originally been set to end.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled lower in range 0.60% to 1%.
  • European equity markets also ended lower in range 0.24% to 1.56%.
  • Asian equity markets are trading mix.
  • GIFT Nifty is up by 70 points, Nifty futures likely to open around 24950 levels.

 

News highlights from across the globe

  • US and European equity-index futures climbed alongside Asian markets on Monday following President Donald Trump’s decision to extend the deadline for imposing aggressive European tariffs.
  • Dollar fluctuated after dropping to its lowest level since December 2023. The yen and Swiss franc, which had gained significantly on Friday.
  • Wall Street was shaken as President Donald Trump threatened to impose aggressive tariffs on the European Union and Apple leading to a decline in stocks and the dollar falling to its lowest level since December 2023.

 

Important news updates from the domestic front

  • Glenmark Pharma Q4 FY25 Results Highlights (Consolidated, YoY) revenue up 6.3% at Rs 3,256 crore versus Rs 3,063 crore. Ebitda up 11% at Rs 561 crore versus Rs 504 crore. Margin at 17.2% versus 16.5%. Net Profit at Rs 4.7 crore versus a loss of Rs 1,218 crore. Exceptional Item of Rs 373 crore vs 447 crore Loss in Q4FY24 due to higher tax expense of Rs 1,769 crore.
  • Aditya Birla Fashion Q4 Highlights (Consolidated, YoY) revenue up 9.2% at Rs 1,719.5 crore versus Rs 1,575 crore. Ebita At Rs 205 crore versus Rs 35 crore. Margin at 12% versus 2.2%. Net loss at Rs 161 crore versus loss of Rs 287 crore.
  • JSW Steel Q4 Highlights (Consolidated, QoQ) revenue up 8.3% to Rs 44,819.00 crore versus Rs 41,378.00 crore. Ebitda up 14.3% to Rs 6,378 crore versus Rs 5,579 crore. Margin at 14.2% versus 13.5%. Net profit up 109.6% to Rs 1,503 crore versus Rs 717 crore.
  • Bharti Airtel: The Supreme Court has dismissed Bharti Airtel arm Bharti Telemedia Ltd.’s appeal against high court judgements to levy entertainment tax on DTH services. The total estimated exposure pursuant to judgement at Rs 585 crore.
  • Lloyds Engineering Works received an order worth Rs 21 crore from Cochin Shipyard to supply fin stabiliser systems.
  • Lupin: US unit converts $41 million loan and outstanding interest of $3.3 million to Lupin Oncology into equity. Upon conversion of loan, Lupin oncology becomes step-down subsidiary of the company.
  • Sun Pharma will make an investment of $25 million in US-based Pharmazz.
  • Zydus Lifesciences received USFDA nod for Isotretinoin Capsules USP – 10 mg, 20 mg, 25 mg, 30 mg, 35 mg and 40 mg.
  • Bajaj Auto’s arm is in Call Option agreement with Pierer Konzerngesellschaft mbH and Pierer Industrie AG for right to purchase from Pierer Industrie AG the shares held in Pierer Bajaj AG.
  • Havells is set to make an investment of Rs 340 crore to further hike cables capacity in Alwar. Alwar Plant total annual capacity of cables to be 41.45 lakh Km.
  • Inox Wind: NCLT approved the scheme of arrangement between Inox Wind Energy, Inox Wind and shareholders.
  • Roto Pumps reports embezzlement of Rs 2 to Rs 2.5 crore funds of arm by its director Ravin Munsook Sewnarain.

 

Nifty Overview & Outlook

Benchmark Nifty index ended higher at 24853 levels after adding 243 points to its previous closing values.

Broader markets settled higher in line with the benchmark as Mid and Small cap indices gained 0.64% & 0.80% respectively.

All sectoral indices, barring Pharma, tracked at NSE ended in green , Amongst them, Nifty FMCG index gained maximum, added 1.63% followed by Private Bank and Fin Services that rose over 1% each.

Nifty index bounced back sharply from the supports of 24480 spot levels. Going ahead, we continue to uphold our bullish view on Nifty index till it is trading above 24480 spot levels. Cross and sustenance above 25120 spot levels hold the key for further up move up to 25500 spot levels.

 

Derivatives Overview & Outlook

Last Friday, Nifty added 3.1% of open interest as long buildup along with some short covering in Banknifty and Midcapnifty futures with decrease in open interest by 1.5% and 2.8% respectively while no significant change was seen in Finnifty futures on open interest front.

Majority of F&O sectors settled higher. Amongst them, Chemical, Oil & Gas and Power stocks witnessed maximum addition of long positions while some short buildup was seen in Infrastructure and Textile stocks.

On option front, call writing along with some put writing was seen at multiple strikes. Maximum put positions are at 24000 PE followed by 24500 PE and maximum call positions are at 26000 CE followed by 25000 CE.

 

Institutional Trading Activity

Last week, FIIs sold stock worth Rs 10472 Cr in the cash segment, sold stocks futures worth Rs 6089 Cr also sold index futures worth Rs 5687 Cr. DIIs were net buyers in the cash segment to the tune of Rs 11199 Cr during the week.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 25000-25100; Supports 24800-24700

Banknifty – Resistances 55700-56000; Supports 55300-55000

Finnifty – Resistances 26650- 26780; Supports 26400-26300

 

F&O Security in Ban Today: CHAMBALFIRT, DIXON, HINDCOPPER, RBLBANK, MANAPPURAM & TITAGARH

 

Important Results Today: ACE, GICRE, KEC & OLECTRA

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.